Who is TMS indicated for?
TMS includes approved indications and research-stage applications. Eligibility is always defined individually.
FDA-approved applications (United States)
- Treatment-resistant depression.
- Depression with comorbid anxiety.
- Obsessive-compulsive disorder (OCD).
- Substance use support and smoking cessation.
- Selected migraine protocols.
Research-stage applications
- Fibromyalgia.
- Neuropathic pain.
- Migraine (FDA approved in 2013 for specific protocols).
- Autism spectrum disorders.
- Tinnitus.
- Post-stroke rehabilitation.
Medical criteria for TMS indication
For applications under study, indication is case-by-case under strict clinical criteria and always as a complementary therapy, never a replacement for conventional treatment. Medical history, prior treatments, functional status, and therapeutic goals are all considered.